US Patent 11427634 Human anti-semaphorin 4D antibody
Patent 11427634 was granted and assigned to Vaccinex, Inc on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Angelica Cornelison0
Ernest S. Smith0
Maria G. M. Scrivens0
Mark Paris0
Maurice Zauderer0
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114276340
Date of Patent
August 30, 2022
0Patent Application Number
166112090
Date Filed
May 4, 2018
0Patent Primary Examiner
Edits on 31 Aug, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+231 characters)
US Patent 11427634 Human anti-semaphorin 4D antibody
Article
Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11427634
Date of Patent
August 30, 2022
Patent Application Number
16611209
Date Filed
May 4, 2018
Patent Primary Examiner
Find more entities like US Patent 11427634 Human anti-semaphorin 4D antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
